RAIN
XNAS
$1.80
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (RAIN)
Rain Therapeutics Inc., a clinical-stage precision oncology company, is dedicated to developing therapies that target oncogenic drivers in the United States. The company is headquartered in Newark, California.
This company is also listed under the following ticker: RAINW.
Website: https://rainwatertech.comSector:
Industrials
Industry:
Pollution & Treatment Controls
Market Cap
$13M
Free Cash Flow Yield
-28.64%
Beta (5Y)
1.30
Price Chart
Valuation
Market Cap$13M
P/S1615.28
Profitability
Total Revenue (TTM)$11K
Gross Profit (TTM)-$485K
EBITDA-$4.58M
Operating Margin-18341%
EPS-$1.20
Financial Health
Debt-to-Equity-85%
Free Cash Flow Yield-28.64%
Growth & Risk
EPS 5Y CAGR-36.90%
Beta (5Y)1.30
Sharpe Ratio0.10